{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:07:11Z","timestamp":1793156831220,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77859-9","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T16:02:38Z","timestamp":1730649758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular mechanisms at the basis of the protective effect exerted by EPPS on neurodegeneration induced by prefibrillar amyloid oligomers"],"prefix":"10.1038","volume":"14","author":[{"given":"Beatrice","family":"Zarrilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Cariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Cappella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sennato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Giordani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Tancredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Diociaiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"D\u2019Arcangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,3]]},"reference":[{"key":"77859_CR1","doi-asserted-by":"crossref","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl), S10 (2004).","DOI":"10.1038\/nm1066"},{"key":"77859_CR2","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C. & Pritzkow, S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 21, 1332\u20131340 (2018).","journal-title":"Nat. Neurosci."},{"key":"77859_CR3","doi-asserted-by":"crossref","unstructured":"Gao, J. et al. Abnormalities of mitochondrial dynamics in neurodegenerative diseases. Antioxidants (Basel) 6 (2017).","DOI":"10.3390\/antiox6020025"},{"key":"77859_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4103\/1673-5374.322430","volume":"17","author":"F Rey","year":"2022","unstructured":"Rey, F., Ottolenghi, S., Zuccotti, G., Samaja, M. & Carelli, S. Mitochondrial dysfunctions in neurodegenerative diseases: Role in disease pathogenesis, strategies for analysis and therapeutic prospects. Neural Regen Res. 17, 754\u2013758 (2022).","journal-title":"Neural Regen Res."},{"key":"77859_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 8, 101\u2013112 (2007).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"77859_CR6","doi-asserted-by":"crossref","unstructured":"Chiti, F. & Dobson, C. M. Protein & misfolding amyloid formation, and human disease: A summary of progress over the last decade. Annu. Rev. Biochem.  86, 27\u201368  (2017).","DOI":"10.1146\/annurev-biochem-061516-045115"},{"key":"77859_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.neurobiolaging.2005.04.017","volume":"27","author":"CG Glabe","year":"2006","unstructured":"Glabe, C. G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging. 27, 570\u2013575 (2006).","journal-title":"Neurobiol. Aging"},{"key":"77859_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semcdb.2018.03.006","volume":"83","author":"Y Ye","year":"2018","unstructured":"Ye, Y. Regulation of protein homeostasis by unconventional protein secretion in mammalian cells. Semin Cell. Dev. Biol. 83, 29\u201335 (2018).","journal-title":"Semin Cell. Dev. Biol."},{"key":"77859_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/10408369409084679","volume":"31","author":"JD Sipe","year":"1994","unstructured":"Sipe, J. D.  Amyloidosis. Crit. Rev. Clin. Lab. Sci. 31, 325\u2013354 (1994).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"77859_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000103374","volume":"74","author":"A Aigelsreiter","year":"2007","unstructured":"Aigelsreiter, A. et al. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases. Pathobiology 74, 145\u2013158 (2007).","journal-title":"Pathobiology"},{"key":"77859_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-pathol-052016-100200","volume":"12","author":"A Dogan","year":"2017","unstructured":"Dogan, A. Amyloidosis: Insights from proteomics. Annu. Rev. Pathol. 12, 277\u2013304 (2017).","journal-title":"Annu. Rev. Pathol."},{"key":"77859_CR12","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1007\/s12035-018-1334-z","volume":"56","author":"A Kurtishi","year":"2019","unstructured":"Kurtishi, A., Rosen, B., Patil, K. S., Alves, G. W. & M\u00f8ller, S. G. Cellular proteostasis in neurodegeneration. Mol. Neurobiol. 56, 3676\u20133689 (2019).","journal-title":"Mol. Neurobiol."},{"key":"77859_CR13","doi-asserted-by":"crossref","unstructured":"Diociaiuti, M. et al. The Interaction between amyloid prefibrillar oligomers of salmon calcitonin and a lipid-raft model: Molecular mechanisms leading to membrane damage, Ca 2+-influx and neurotoxicity. Biomolecules 10 (2019).","DOI":"10.3390\/biom10010058"},{"key":"77859_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E. & De Strooper, B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: An emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"77859_CR15","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.bbadis.2014.06.006","volume":"1842","author":"M Diociaiuti","year":"2014","unstructured":"Diociaiuti, M. et al. Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates. Biochim. Biophys. Acta Mol. Basis Dis. 1842, 1622\u20131629 (2014).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"77859_CR16","doi-asserted-by":"crossref","unstructured":"Diociaiuti, M., Bonanni, R., Cariati, I. & Frank, C. & D\u2019arcangelo, G. Amyloid prefibrillar oligomers: The surprising commonalities in their structure and activity. Int. J. Mol. Sci. 22 (2021).","DOI":"10.3390\/ijms22126435"},{"key":"77859_CR17","doi-asserted-by":"crossref","unstructured":"Malchiodi-Albedi, F., Paradisi, S., Matteucci, A., Frank, C. &  Diociaiuti, M.  Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts. Int. J. Alzheimer\u2019s Dis. 2011, 906964 (2011).","DOI":"10.4061\/2011\/906964"},{"key":"77859_CR18","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1016\/j.febslet.2015.07.006","volume":"589","author":"V Vetri","year":"2015","unstructured":"Vetri, V. & Foder\u00e0, V. The route to protein aggregate superstructures: Particulates and amyloid-like spherulites. FEBS Lett. 589, 2448\u20132463 (2015).","journal-title":"FEBS Lett."},{"key":"77859_CR19","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1111\/j.1742-4658.2010.07889.x","volume":"277","author":"M Stefani","year":"2010","unstructured":"Stefani, M. Biochemical and biophysical features of both oligomer\/fibril and cell membrane in amyloid cytotoxicity. FEBS J. 277, 4602\u20134613 (2010).","journal-title":"FEBS J."},{"key":"77859_CR20","doi-asserted-by":"crossref","unstructured":"Banerjee, S. & Lyubchenko, Y. L. Interaction of amyloidogenic proteins with membranes and molecular mechanism for the development of Alzheimer\u2019s disease. Alzheimers Res. Ther. Open. Access. 2, 1 (2019).","DOI":"10.23880\/ARTOA-16000106"},{"key":"77859_CR21","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SIA Cohen","year":"2013","unstructured":"Cohen, S. I. A. et al. Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. U S A 110, 9758\u20139763 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"77859_CR22","doi-asserted-by":"crossref","unstructured":"Linse, S. et al. Kinetic fingerprints differentiate the mechanisms of action of anti-A\u03b2 antibodies. Nat. Struct. Mol. Biol. 27, 1125\u20131133 (2020).","DOI":"10.1038\/s41594-020-0505-6"},{"key":"77859_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S., Jones, D. T. & Greicius, M. D. Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimer\u2019s Dement. 17, 696\u2013701 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"77859_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","volume":"20","author":"L S\u00f6derberg","year":"2023","unstructured":"S\u00f6derberg, L. et al. Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease. Neurotherapeutics 20, 195\u2013206 (2023).","journal-title":"Neurotherapeutics"},{"key":"77859_CR25","unstructured":"CHMP. What were the main reasons for refusing the marketing authorisation?."},{"key":"77859_CR26","unstructured":"van Dyck, C. H. C. J. S. P. A. Lecanemab in Early Alzheimer\u2019s Disease."},{"key":"77859_CR27","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1038\/ncomms9997","volume":"6","author":"HY Kim","year":"2015","unstructured":"Kim, H. Y. et al. EPPS rescues hippocampus-dependent cognitive deficits in APP\/PS1 mice by disaggregation of amyloid-\u03b2 oligomers and plaques. Nat. Commun. 6, 8997 (2015).","journal-title":"Nat. Commun."},{"key":"77859_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ijch.201600096","volume":"57","author":"K Kamgar-Parsi","year":"2017","unstructured":"Kamgar-Parsi, K. et al. Structural biology of calcitonin: From aqueous therapeutic properties to amyloid aggregation. Isr. J. Chem. 57, 634\u2013650 (2017).","journal-title":"Isr. J. Chem."},{"key":"77859_CR29","doi-asserted-by":"publisher","first-page":"9277","DOI":"10.3390\/ijms12129277","volume":"12","author":"M Diociaiuti","year":"2011","unstructured":"Diociaiuti, M., Gaudiano, M. C. & Malchiodi-Albedi, F. The slowly aggregating salmon Calcitonin: A useful tool for the study of the amyloid oligomers structure and activity. Int. J. Mol. Sci. 12, 9277\u20139295 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"77859_CR30","doi-asserted-by":"crossref","unstructured":"Kayed, R. & Lasagna-Reeves, C. A. Molecular mechanisms of amyloid oligomers toxicity. J. Alzheimers Dis. 33(Suppl 1) (2013).","DOI":"10.3233\/JAD-2012-129001"},{"key":"77859_CR31","doi-asserted-by":"publisher","first-page":"12447","DOI":"10.1021\/jp903106x","volume":"113","author":"S Xu","year":"2009","unstructured":"Xu, S. Cross-beta-sheet structure in amyloid fiber formation. J. Phys. Chem. B 113, 12447\u201312455 (2009).","journal-title":"J. Phys. Chem. B"},{"key":"77859_CR32","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1038\/s41598-019-41462-0","volume":"9","author":"M Belfiore","year":"2019","unstructured":"Belfiore, M. et al. Calcitonin native prefibrillar oligomers but not monomers induce membrane damage that triggers NMDA-mediated Ca(2+)-influx, LTP impairment and neurotoxicity. Sci. Rep. 9, 5144 (2019).","journal-title":"Sci. Rep."},{"key":"77859_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.4103\/1673-5374.121636","volume":"8","author":"M He","year":"2013","unstructured":"He, M., Liu, J., Cheng, S., Xing, Y. & Suo, W. Z. Differentiation renders susceptibility to excitotoxicity in HT22 neurons. Neural Regen. Res. 8, 1297\u20131306 (2013).","journal-title":"Neural Regen Res."},{"key":"77859_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0959-440X(02)00351-2","volume":"12","author":"E London","year":"2002","unstructured":"London, E. Insights into lipid raft structure and formation from experiments in model membranes. Curr. Opin. Struct. Biol. 12, 480\u2013486 (2002).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"77859_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/35036052","volume":"1","author":"K Simons","year":"2000","unstructured":"Simons, K. & Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1, 31\u201339 (2000).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"77859_CR36","doi-asserted-by":"crossref","unstructured":"Manna, M. & Mukhopadhyay, C. Binding, conformational transition and dimerization of amyloid-\u03b2 peptide on GM1-containing ternary membrane: Insights from molecular dynamics simulation. PLoS ONE 8 (2013).","DOI":"10.1371\/journal.pone.0071308"},{"key":"77859_CR37","doi-asserted-by":"crossref","unstructured":"Fantini, J., Yahi, N. & Garmy, N. Cholesterol accelerates the binding of Alzheimer\u2019s \u03b2-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation. Front. Physiol. 4 (2013).","DOI":"10.3389\/fphys.2013.00120"},{"key":"77859_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1006\/jcis.1997.4789","volume":"189","author":"B De Meulenaer","year":"1997","unstructured":"De Meulenaer, B., Van Der Meeren, P., De Cuyper, M., Vanderdeelen, J. & Baert, L. Electrophoretic and dynamic light scattering study of the interaction of cytochrome c with dimyristoylphosphatidylglycerol, dimyristoylphosphatidylcholine, and intramembranously mixed liposomes. J. Colloid Interface Sci. 189, 254\u2013258 (1997).","journal-title":"J. Colloid Interface Sci."},{"key":"77859_CR39","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1073\/pnas.96.11.6020","volume":"96","author":"DA Fancy","year":"1999","unstructured":"Fancy, D. A. & Kodadek, T. Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light. Proc. Natl. Acad. Sci. U S A 96, 6020\u20136024 (1999).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"77859_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0076-6879(06)13012-8","volume":"413","author":"G Bitan","year":"2006","unstructured":"Bitan, G. Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins. Methods Enzymol. 413, 217\u2013236 (2006).","journal-title":"Methods Enzymol."},{"key":"77859_CR41","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1074\/jbc.M310882200","volume":"279","author":"G Andreotti","year":"2004","unstructured":"Andreotti, G. & Motta, A. Modulating calcitonin fibrillogenesis: An antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin. J. Biol. Chem. 279, 6364\u20136370 (2004).","journal-title":"J. Biol. Chem."},{"key":"77859_CR42","doi-asserted-by":"crossref","unstructured":"Cariati, I. et al. Role of electrostatic interactions in calcitonin prefibrillar oligomer-induced amyloid neurotoxicity and protective effect of neuraminidase. Int. J. Mol. Sci. 22 (2021).","DOI":"10.3390\/ijms22083947"},{"key":"77859_CR43","first-page":"365","volume":"8","author":"M Diociaiuti","year":"2016","unstructured":"Diociaiuti, M. et al. Monosialoganglioside-GM1 triggers binding of the amyloid-protein salmon calcitonin to a Langmuir membrane model mimicking the occurrence of lipid-rafts. Biochem. Biophys. Rep. 8, 365\u2013375 (2016).","journal-title":"Biochem. Biophys. Rep."},{"key":"77859_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JAD-2010-100183","volume":"22","author":"HY Kim","year":"2010","unstructured":"Kim, H. Y., Kim, Y., Han, G. & Kim, D. J. Regulation of in vitro A\u03b21\u201340 aggregation mediated by small molecules. J. Alzheimers Dis. 22, 73\u201385 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"77859_CR45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"77859_CR46","doi-asserted-by":"publisher","first-page":"46363","DOI":"10.1074\/jbc.C400260200","volume":"279","author":"R Kayed","year":"2004","unstructured":"Kayed, R. et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363\u201346366 (2004).","journal-title":"J. Biol. Chem."},{"key":"77859_CR47","doi-asserted-by":"crossref","unstructured":"Diociaiuti, M., Fioravanti, R. & Belfiore, M. Neurotoxic amyloid prefibrillar oligomers: Do salmon calcitonin and amyloid \u03b21\u201342 wear the same outfit? Arch. Clin. Toxicol. (Middlet) 2, (2021).","DOI":"10.46439\/toxicology.2.011"},{"key":"77859_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0960-894X(01)81162-8","volume":"1","author":"JA Barltrop","year":"1991","unstructured":"Barltrop, J. A., Owen, T. C., Cory, A. H. & Cory, J. G. 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators. Bioorg. Med. Chem. Lett. 1, 611\u2013614 (1991).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"77859_CR49","first-page":"330","volume":"55","author":"M Palmieri","year":"2019","unstructured":"Palmieri, M. et al. Effects of short-term aerobic exercise in a mouse model of Niemann-Pick type C disease on synaptic and muscle plasticity. Ann. Ist Super Sanit\u00e0. 55, 330\u2013337 (2019).","journal-title":"Ann. Ist Super Sanit\u00e0"},{"key":"77859_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1364\/AO.40.003995","volume":"40","author":"WW Tscharnuter","year":"2001","unstructured":"Tscharnuter, W. W. Mobility measurements by phase analysis. Appl. Opt. 40, 7\u20139 (2001).","journal-title":"Appl. Opt."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77859-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T16:02:52Z","timestamp":1730649772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77859-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,3]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77859"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77859-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,3]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26533"}}